| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Life Science • Pharmaceutical (& Medicine) • Diagnostics |
| Stages | Pre-seed, Seed |
| Investing | United States • United Kingdom • Australia |
| Investment Range | $100,000 - $500,000 |
Day Zero is an early-stage venture fund backing founders at the earliest stage of company building. We invest in pre-seed and seed startups across AI, HealthTech, BioTech, and Automation, supporting ambitious teams from day zero to global scale.
Day Zero is an early-stage venture fund backing founders at the earliest stage of company building. We invest in pre-seed and seed startups across AI, HealthTech, BioTech, and Automation, supporting ambitious teams from day zero to global scale.
What we look for: We invest in pre-seed and seed startups across artificial intelligence, health technology, biotechnology, and automation. Day Zero partners with ambitious founders from the first day of their journey and supports them from idea to global scale.
How we help: We support founders beyond capital by helping with early product strategy, hiring, and fundraising preparation. Our portfolio companies also gain access to a strong partner ecosystem providing over $150K+ in startup infrastructure, cloud, and software credits, along with introductions to operators, investors, and global startup networks.
